Additional concern: Studies have linked a rare, sudden vision loss condition called NAION (non-arteritic anterior ischemic optic neuropathy) to Ozempic
(Some NASH trials look at these endpoints in the reverse order.) More participants taking any dose of semaglutide experienced NASH resolution (40%, 36% and 59%, respectively, in the 0.1, 0.2, and 0.4 mg dose groups) compared with the placebo arm (17%)
Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options
Balance and stability work
Research indicates that carnitine deficiency is common in insulin-resistant states including type 2 diabetes, with levels inversely correlating with insulin resistance severity
An rDBS device is different from a regular DBS device in that it stimulates only when it detects a predefined biomarker rather than stimulating continuously